BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 18, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 27, 2006

View Archived Issues

ALS Association awards research funding to Sirtris

Read More

Safetek signs term sheet with Resdevco

Read More

Dynavax Technologies completes acquisition of Rhein Biotech GmbH

Read More

Apaziquone highly active in superficial bladder cancer

Read More

Teverelix shows promise in phase II prostate cancer study

Read More

Tolterodine improves overactive bladder symptoms and patient quality of life

Read More

SUNRISE study reveals urinary urgency improvement with solifenacin

Read More

hMaxi-K gene transfer for erectile dysfunction safe in phase I study

Read More

Dose proportionality confirmed with BEMA Fentanyl

Read More

Antinociceptive activity of neurotoxin receptor site 2-targeting sodium channel blocker

Read More

Disappointing results from phase III trial of bicifadine in chronic low back pain

Read More

IND approval for Aurora kinase inhibitor AT-9283

Read More

Phase II picoplatin study expanded into Eastern Europe

Read More

Panzem NCD with paclitaxel studied for metastatic breast cancer

Read More

DOD grant supports study of bavituximab in breast cancer

Read More

Enrollment completed in study of Chondrogen to repair tissue in the knee

Read More

PhytoMedical to focus on development of specific polyphenols

Read More

Series B financing at Protez to support development of PZ-601

Read More

Target enrollment completed in phase IIa study of E1-I.N.T. for type 2 diabetes

Read More

New Asian study for Iressa in first-line NSCLC

Read More

Lixivaptan demonstrates aquaretic effects in heart failure patients

Read More

ZT-1 evaluated in vivo, in healthy subjects and in Alzheimer's disease patients

Read More

European approval and recommendation for new Keppra indications

Read More

European approval for Preotact

Read More

Vaprisol launched for treatment of euvolemic hyponatremia

Read More

Roche seeks European approval for novel anemia drug CERA

Read More

Coagulation factor Xa inhibitors prepared and tested at Merck

Read More

Recent Bayer patent imparts novel agents for lipoprotein-related disorders

Read More

Two recent Pfizer patents describe new histamine H3 receptor antagonists

Read More

Newly formed Abraxis Bioscience presents data on nab tumor targeting technology

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing